Trial Profile
Efficacy of Favipiravir Against Severe Ebola Virus Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Oct 2016
Price :
$35
*
At a glance
- Drugs Favipiravir (Primary)
- Indications Ebola virus infections
- Focus Therapeutic Use
- 23 Aug 2016 Results of a retrospective clinical case series from this trial published in the Clinical Infectious Diseases
- 05 Feb 2016 New trial record